Denny Heck sold Bristol-Myers Squibb Company (NYSE: BMY)
Denny Heck (D-WA), a U.S. Representative, has disclosed 1 trade in Bristol-Myers Squibb Company (BMY) since 2017, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Denny Heck sold $1,001 - $15,000 of Bristol-Myers Squibb Company (NYSE: BMY) on September 25, 2017. Since that trade, BMY is up +22.76% against the S&P 500 up +244.65%, an outperformance of -221.90%.
Data updated
Denny Heck's BMY trades vs the price
BMY is up +22.76% since Denny Heck sold on September 25, 2017, versus +244.65% for the S&P 500.
Performance since this trade
All Denny Heck BMY trades
Denny Heck & BMY trading FAQ
Is it legal for Denny Heck to trade Bristol-Myers Squibb Company (BMY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Bristol-Myers Squibb Company (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Denny Heck sell BMY?
Denny Heck disclosed a sale of $1,001 - $15,000 of Bristol-Myers Squibb Company (BMY) on September 25, 2017, according to public STOCK Act filings.
How has BMY performed since Denny Heck's trade?
Since Denny Heck sold BMY on September 25, 2017, the stock is up +22.76%, versus +244.65% for the S&P 500 over the same period, an outperformance of -221.90%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMY trades?
BullishWhales tracks every disclosed congressional trade in Bristol-Myers Squibb Company (BMY) on the Bristol-Myers Squibb Company congressional trading page, which aggregates filings across all members of Congress.
Denny Heck's BMY tradesAll congressional filings for Bristol-Myers Squibb CompanyDenny Heck's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.